Skip to content

Latigo Biotherapeutics, Inc.

LTGO · XNAS

CIK 2056611fmd_1WDK9G6AZ3ZS2DW5G071DYWWQRManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2025 to Sep 30, 2026, 7 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading